CellTran is a biotechnology company engaged in the development of cell therapy products for the wound management industry.
CellTran Limited engages in the research and development of products for the regeneration of tissue and the healing of wounds. The company offers Myskin that is used for the treatment of difficult to heal wounds; Lyphoderm, a freeze-dried lysate from cultured human keratinocytes that is formulated into a hydrophilic gel; and Ulcodress, an integrated wound care dressing that provides control of moisture, infection, and proteases within the wound area. It provides skin banking services, as well as contract manufacture services in the fields of materials fabrication and cell culture. The company was founded in 2000 and is based in Sheffield, the United Kingdom. As of October 28, 2008, CellTran Limited operates as a subsidiary of York Pharma plc.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 21, 2007 | Series Unknown | £1M | 1 | — | — | Detail |
Aug 9, 2005 | Series Unknown | $4.82M | 2 | — | — | Detail |
Feb 1, 2005 | Series Unknown | $470K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
PUK Ventures | — | Series Unknown |
Spirit Capital Partners | — | Series Unknown |
Partnerships UK | — | Series Unknown |
SMH Venture Finance Limited | — | Series Unknown |